荃信生物

2024-3-20 HKEX

Listed(Code:02509.HK)

专注于自身免疫及过敏性疾病生物疗法，拥有完全自主研发的药物管线和已建成的商业级规模的生产能力。

https://www.qyuns.net/

东星医疗

2022-11-30 IPO

Listed（301290）

微创手术腔镜吻合器领域龙头企业

http://www.dx-med.com/

AIM

2022-10-06 IPO

IPO (06660.HK)

在产在研的产品覆盖了世界排名前十的所有疫苗产品。

http://www.aimbio.com/

联影医疗

2022-08-22 IPO上市

已上市（代码：688271 ）

全球少数几家产品线覆盖全线高端医疗影像及放疗设备，并同时拥有全球领先核心技术的医疗科技企业之一，有力推动了我国高端医疗装备技术全面自主可控。

https://www.united-imaging.com/

润迈德医疗

2022-07-08 IPO上市

已上市（代码：02297.HK）

专注于冠状动脉造影血流储备分数（caFFR）系统及冠状动脉造影微血管阻力指数（caIMR）系统的设计、研发及商业化，致力于成为全球领先的血管介入手术机器人公司。

https://www.rainmed.com/

acrobiosystems

2021-10-18 IPO上市

已上市（代码：301080）

Founded in the North American market, the leading brand of recombinant protein, in the drug development process to provide the required high-quality target protein for major customers to provide one-stop protein reagent solution.

http://www.acrobiosystems.cn/

堃博医疗

2021-09-24 IPO上市

已上市（代码：02216.HK）

专注于介入呼吸病学产品开发，是介入呼吸病学领域的开拓者，在中国和全球范围内提供创新型肺部疾病解决方案。

The essence of medical sciences

2021-05-21 IPO上市

已上市（代码：688613）

It is a sino-foreign joint venture that focuses on the operation and development of medical implant devices with independent intellectual property rights.

http://www.allgensmed.cn/

Tinavi

2020-07-07 IPO上市

已上市（代码：688277）

To computer-aided surgical navigation and medical robots as the core, to provide intelligent minimally invasive surgery overall solution, Zhongguancun Medical Device Industry Technology Innovation Alliance chairman unit.

http://cn.tinavi.com/

GuiZhou Sanli

2020-04-28 IPO上市

已上市（代码：603439）

It is a modern Chinese patent medicine pharmaceutical enterprise integrating R&D, production, and sales. An enterprise engaged in the research and development, production, and sales of Chinese patent medicines for throat diseases, cardiovascular and cereb

https://www.gz-sanli.com/

Venusmedtech

2019-12-10 IPO上市

Listed(Venusmedtech:02500.HK)

The Company’s self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration ("NMPA") and commercialized in China.

http://www.venusmedtech.com/

lifotronic

2019-11-05 IPO上市

已上市（代码：688389）

Committed to in vitro diagnostic equipment and bedside rehabilitation equipment research and development and industrialization, 2015 National Science and Technology Progress Award.

http://www.lifotronic.com/